These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 32268165

  • 21. Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway.
    Zhou Y, Zhang M, Zhang Z, Jia Y, Zhang C, Peng L.
    Biomed Pharmacother; 2020 Sep; 129():109851. PubMed ID: 32559627
    [Abstract] [Full Text] [Related]

  • 22. Investigation of prunetrin induced G2/M cell cycle arrest and apoptosis via Akt/mTOR/MAPK pathways in hepatocellular carcinoma cells.
    Abusaliya A, Bhosale PB, Kim HH, Park MY, Jeong SH, Lee S, Kim GS.
    Biomed Pharmacother; 2024 May; 174():116483. PubMed ID: 38552440
    [Abstract] [Full Text] [Related]

  • 23. The anti-tumor activities of Neferine on cell invasion and oxaliplatin sensitivity regulated by EMT via Snail signaling in hepatocellular carcinoma.
    Deng G, Zeng S, Ma J, Zhang Y, Qu Y, Han Y, Yin L, Cai C, Guo C, Shen H.
    Sci Rep; 2017 Jan 30; 7():41616. PubMed ID: 28134289
    [Abstract] [Full Text] [Related]

  • 24. Local anesthetic bupivacaine inhibits proliferation and metastasis of hepatocellular carcinoma cells via suppressing PI3K/Akt and MAPK signaling.
    Wang L, Guo W, Guan H, Yan N, Cai X, Zhu L.
    J Biochem Mol Toxicol; 2021 Oct 30; 35(10):e22871. PubMed ID: 34338398
    [Abstract] [Full Text] [Related]

  • 25. Pogostemon cablin Triggered ROS-Induced DNA Damage to Arrest Cell Cycle Progression and Induce Apoptosis on Human Hepatocellular Carcinoma In Vitro and In Vivo.
    Huang XF, Sheu GT, Chang KF, Huang YC, Hung PH, Tsai NM.
    Molecules; 2020 Nov 30; 25(23):. PubMed ID: 33266043
    [Abstract] [Full Text] [Related]

  • 26. β-Thujaplicin induces autophagic cell death, apoptosis, and cell cycle arrest through ROS-mediated Akt and p38/ERK MAPK signaling in human hepatocellular carcinoma.
    Zhang G, He J, Ye X, Zhu J, Hu X, Shen M, Ma Y, Mao Z, Song H, Chen F.
    Cell Death Dis; 2019 Mar 15; 10(4):255. PubMed ID: 30874538
    [Abstract] [Full Text] [Related]

  • 27. Strategy to enhance the therapeutic effect of doxorubicin in human hepatocellular carcinoma by selenocystine, a synergistic agent that regulates the ROS-mediated signaling.
    Fan C, Zheng W, Fu X, Li X, Wong YS, Chen T.
    Oncotarget; 2014 May 15; 5(9):2853-63. PubMed ID: 24797310
    [Abstract] [Full Text] [Related]

  • 28. Bioactive components and mechanisms of poplar propolis in inhibiting proliferation of human hepatocellular carcinoma HepG2 cells.
    Liu H, Li J, Yuan W, Hao S, Wang M, Wang F, Xuan H.
    Biomed Pharmacother; 2021 Dec 15; 144():112364. PubMed ID: 34700230
    [Abstract] [Full Text] [Related]

  • 29. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
    Wang C, Gao D, Guo K, Kang X, Jiang K, Sun C, Li Y, Sun L, Shu H, Jin G, Sun H, Wu W, Liu Y.
    BMC Cancer; 2012 May 04; 12():166. PubMed ID: 22559167
    [Abstract] [Full Text] [Related]

  • 30. Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells.
    Dong J, Zhai B, Sun W, Hu F, Cheng H, Xu J.
    PLoS One; 2017 May 04; 12(9):e0185088. PubMed ID: 28934275
    [Abstract] [Full Text] [Related]

  • 31. Anlotinib induces hepatocellular carcinoma apoptosis and inhibits proliferation via Erk and Akt pathway.
    He C, Wu T, Hao Y.
    Biochem Biophys Res Commun; 2018 Sep 18; 503(4):3093-3099. PubMed ID: 30146257
    [Abstract] [Full Text] [Related]

  • 32. (-)-Oleocanthal inhibits growth and metastasis by blocking activation of STAT3 in human hepatocellular carcinoma.
    Pei T, Meng Q, Han J, Sun H, Li L, Song R, Sun B, Pan S, Liang D, Liu L.
    Oncotarget; 2016 Jul 12; 7(28):43475-43491. PubMed ID: 27259268
    [Abstract] [Full Text] [Related]

  • 33. Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.
    Singh AR, Joshi S, Burgoyne AM, Sicklick JK, Ikeda S, Kono Y, Garlich JR, Morales GA, Durden DL.
    Mol Cancer Ther; 2016 Nov 12; 15(11):2553-2562. PubMed ID: 27496136
    [Abstract] [Full Text] [Related]

  • 34. Activation of reactive oxygen species-mediated mitogen-activated protein kinases pathway regulates both extrinsic and intrinsic apoptosis induced by arctigenin in Hep G2.
    Lu Z, Zhou H, Zhang S, Dai W, Zhang Y, Hong L, Chen F, Cao J.
    J Pharm Pharmacol; 2020 Jan 12; 72(1):29-43. PubMed ID: 31617221
    [Abstract] [Full Text] [Related]

  • 35. A novel multitarget kinase inhibitor BZG with potent anticancer activity in vitro and vivo enhances efficacy of sorafenib through PI3K pathways in hepatocellular carcinoma cells.
    Wang L, Zhan Y, Wu Z, Lin M, Jin X, Jiang L, Qiu Y.
    Biomed Pharmacother; 2020 May 12; 125():110033. PubMed ID: 32187962
    [Abstract] [Full Text] [Related]

  • 36. Ophiopogonin‑B targets PTP1B to inhibit the malignant progression of hepatocellular carcinoma by regulating the PI3K/AKT and AMPK signaling pathways.
    Yuan F, Gao Q, Tang H, Shi J, Zhou Y.
    Mol Med Rep; 2022 Apr 12; 25(4):. PubMed ID: 35169857
    [Abstract] [Full Text] [Related]

  • 37. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
    Karkampouna S, van der Helm D, Gray PC, Chen L, Klima I, Grosjean J, Burgmans MC, Farina-Sarasqueta A, Snaar-Jagalska EB, Stroka DM, Terracciano L, van Hoek B, Schaapherder AF, Osanto S, Thalmann GN, Verspaget HW, Coenraad MJ, Kruithof-de Julio M.
    J Pathol; 2018 Jul 12; 245(3):297-310. PubMed ID: 29604056
    [Abstract] [Full Text] [Related]

  • 38. Tunicamycin inhibits cell proliferation and migration in hepatocellular carcinoma through suppression of CD44s and the ERK1/2 pathway.
    Hou H, Ge C, Sun H, Li H, Li J, Tian H.
    Cancer Sci; 2018 Apr 12; 109(4):1088-1100. PubMed ID: 29377347
    [Abstract] [Full Text] [Related]

  • 39. Inhibition of cancer cell growth by oleanolic acid in multidrug resistant liver carcinoma is mediated via suppression of cancer cell migration and invasion, mitochondrial apoptosis, G2/M cell cycle arrest and deactivation of JNK/p38 signalling pathway.
    Gao C, Li X, Yu S, Liang L.
    J BUON; 2019 Apr 12; 24(5):1964-1969. PubMed ID: 31786862
    [Abstract] [Full Text] [Related]

  • 40. Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma.
    Su Q, Fan M, Wang J, Ullah A, Ghauri MA, Dai B, Zhan Y, Zhang D, Zhang Y.
    Cell Death Dis; 2019 Dec 09; 10(12):939. PubMed ID: 31819036
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.